22nd Century Group Cuts $1.5M Debt, Extends Loan Balance
22nd Century Group cuts debt by $1.5M, aiming for financial stability and progress in tobacco harm reduction using advanced technology.
- Latest
- Trending
22nd Century Group cuts debt by $1.5M, aiming for financial stability and progress in tobacco harm reduction using advanced technology.
"AI in Medical Diagnostics set to skyrocket to USD 30.76 billion by 2032, driven by rapid advancements and major industry ...
Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.
"ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
"Futures mixed as investors await inflation data; Nvidia slips, Fed's rate cut predictions diverge from market expectations. Key premarket movers ...
Invest-NL’s Deep Tech Fund injects $26M into Qblox, boosting Dutch ambitions in global quantum technology. The Netherlands eyes leadership in ...
"Numinus Wellness acquires MedBright AI, merging AI with psychedelics for advanced mental health care and expanded services in the U.S."
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.